96 related articles for article (PubMed ID: 10424564)
1. Hyaluronan fragments induce plasminogen activator inhibitor-1 and inhibit urokinase activity in mouse alveolar macrophages: a potential mechanism for impaired fibrinolytic activity in acute lung injury.
Horton MR; Olman MA; Noble PW
Chest; 1999 Jul; 116(1 Suppl):17S. PubMed ID: 10424564
[No Abstract] [Full Text] [Related]
2. Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages.
Horton MR; Olman MA; Bao C; White KE; Choi AM; Chin BY; Noble PW; Lowenstein CJ
Am J Physiol Lung Cell Mol Physiol; 2000 Oct; 279(4):L707-15. PubMed ID: 11000131
[TBL] [Abstract][Full Text] [Related]
3. Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways.
Idell S
Crit Care Med; 2002 May; 30(5 Suppl):S274-80. PubMed ID: 12004248
[TBL] [Abstract][Full Text] [Related]
4. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic activity in bronchoalveolar lavage of baboons with diffuse alveolar damage: trends in two forms of lung injury.
Idell S; James KK; Coalson JJ
Crit Care Med; 1992 Oct; 20(10):1431-40. PubMed ID: 1395665
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activation by blood monocytes and alveolar macrophages in primary pulmonary hypertension.
Martin I; Humbert M; Marfaing-Koka A; Capron F; Wolf M; Meyer D; Simonneau G; Anglés-Cano E
Blood Coagul Fibrinolysis; 2002 Jul; 13(5):417-22. PubMed ID: 12138369
[TBL] [Abstract][Full Text] [Related]
8. A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase.
Gong L; Proulle V; Fang C; Hong Z; Lin Z; Liu M; Xue G; Yuan C; Lin L; Furie B; Flaumenhaft R; Andreasen P; Furie B; Huang M
J Cell Mol Med; 2016 Oct; 20(10):1851-60. PubMed ID: 27197780
[TBL] [Abstract][Full Text] [Related]
9. Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
Moniwa N
Pol J Pharmacol; 1996; 48(2):215-20. PubMed ID: 9112654
[TBL] [Abstract][Full Text] [Related]
10. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.
Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
Int J Cancer; 2002 Dec; 102(4):379-89. PubMed ID: 12402308
[TBL] [Abstract][Full Text] [Related]
11. Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome.
Viscardi RM; Broderick K; Sun CC; Yale-Loehr AJ; Hessamfar A; Taciak V; Burke KC; Koenig KB; Idell S
Am Rev Respir Dis; 1992 Aug; 146(2):492-9. PubMed ID: 1489146
[TBL] [Abstract][Full Text] [Related]
12. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
[TBL] [Abstract][Full Text] [Related]
13. Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor.
Fan J; Kapus A; Li YH; Rizoli S; Marshall JC; Rotstein OD
Am J Respir Cell Mol Biol; 2000 Apr; 22(4):412-21. PubMed ID: 10745022
[TBL] [Abstract][Full Text] [Related]
14. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activators and inhibitor type-1 in alveolar osteitis.
Serratì S; Margheri F; Bruschi S; D'Alessio S; Pucci M; Fibbi G; Tonelli P; Del Rosso M
Eur J Oral Sci; 2006 Dec; 114(6):500-3. PubMed ID: 17184232
[TBL] [Abstract][Full Text] [Related]
16. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
17. Regulation and interactions in the activation of cell-associated plasminogen.
Myöhänen H; Vaheri A
Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213
[TBL] [Abstract][Full Text] [Related]
18. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome.
Ware LB; Matthay MA; Parsons PE; Thompson BT; Januzzi JL; Eisner MD;
Crit Care Med; 2007 Aug; 35(8):1821-8. PubMed ID: 17667242
[TBL] [Abstract][Full Text] [Related]
19. Vascular cell-derived fibrinolytic regulators and atherothrombotic vascular disorders (Review).
Shen GX
Int J Mol Med; 1998 Feb; 1(2):399-408. PubMed ID: 9852242
[TBL] [Abstract][Full Text] [Related]
20. Secreted Bacillus anthracis proteases target the host fibrinolytic system.
Chung MC; Jorgensen SC; Tonry JH; Kashanchi F; Bailey C; Popov S
FEMS Immunol Med Microbiol; 2011 Jul; 62(2):173-81. PubMed ID: 21395696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
